|
|
|
|
|
| Available: 0 |
| List Price:$609.00 |
|
Other formats:
|
| Edition: | 1st |
| Publisher: | Springer Nature |
| ISBN: | 3-540-89614-7 (3540896147) |
| ISBN-13: | 978-3-540-89614-2 (9783540896142) |
| Binding: | Hardcover |
| Copyright: | 2009 |
| Publish Date: | 09/09 |
| Volume: | 193 |
| Weight: | 2.35 Lbs. |
| Pages: | 652 |
| Subject Class: | PRM (Pharmacology) |
| Remarks: | Print on Demand. Please allow additional time for delivery. |
| Return Policy: | Returns accepted up to 12 months provided no other recalls or return restrictions apply. |
| Table Of Contents: |
View
|
| Contributing Authors: |
View
|
| ProQuest Ebook Central: |
Available in ProQuest Ebook Central™ View
|
|
|
| |
| ISSN Series: | Handbook of Experimental Pharmacology | | Discipline: | Biochemistry | | Subject Definition: | Receptors, Purinergic P1-Antagonists & Inhibitors | | NLM Class: | QU 58 | | LC Class: | QP625 | | Abstract: | Since their discovery approximately 25 years ago, adenosine receptors have now emerged as important novel molecular targets in disease and drug discovery. These proteins play important roles in the entire spectrum of disease from inflammation to immune suppression. Because of their expression on a number of different cell types and in a number of different organ systems they play important roles in specific diseases, including asthma, rheumatoid arthritis, Parkinson's disease, multiple sclerosis, Alzheimer's disease, heart disease, stroke, cancer, sepsis, and obesity. As a result of intense investigations into understanding the molecular structures and pharmacology of these proteins, new molecules have been synthesized that have high specificity for these proteins and are now entering clinical trials. These molecules will define the next new classes of drugs for a number of diseases with unmet medical needs. |
|
|
|
|
|
|
Follow Matthews Book Co. on:
Copyright © 2001-2024 Matthews Book Company - All rights reserved. - 11559 Rock Island Ct., Maryland Heights, MO, 63043 - (800) MED-BOOK
Matthews